SMC2 and urinary bladder carcinoma: Results from reporter assays using the specific Smad reporter vector showed that rhTGFβ treatments upregulated the reporter activity; however, co-treatment with CAPE reversed such effect in bladder carcinoma HT1376 cells (Figure 4C).